The Early Translational Branch of the National Center for Advancing Translation Sciences, Division of Preclinical Innovation, is now seeking applications from exceptional candidates for a postdoctoral fellowship.
The Early Translational Branch’s mission is to develop new therapeutic approaches in areas of medical need. The branch partners with external collaborators who specialize in specific disorders, creating a multidisciplinary team of innovative scientists with expertise in assay development, high-throughput and high-content screening, automation engineering, bioinformatics, and various -omics technologies.
The selected postdoctoral fellow will use, under the mentorship of a ETB biology team leader, cutting-edge cell biology and bioassay technologies to develop disease-relevant screening assays. They will be involved in all aspects of the implementation of small-molecule screening programs, including assay design, assay development and optimization, high-throughput screening, data analysis, and mechanism-of-action studies, with the goal of developing assay technologies and novel pharmacological probes.
The selected candidate must be able to work both independently and under team supervision. He or she will need to keep accurate records of all scientific experiments according to our established procedures and ensure that these records and raw data are retained properly. The candidate also will draft technical reports and manuscripts, as well as present their work internally and to external collaborators.
Prospective applicants must have (or expect to receive soon) a Ph.D. in cell biology, molecular biology, pharmacology or a related discipline and less than three years of postdoctoral experience. Applicants interested in furthering their knowledge and exposure to translational science are encouraged to apply, as prior high-throughput screening experience is not a prerequisite. The selected candidate should be an independent thinker, a team player, and be able to work in an interactive, fast-paced environment.
